Publication | Closed Access

Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22/STAT3 pathway

InflammationFibrosisLiver FibrosisHepatologyIl-22/stat3 PathwayLiver PhysiologyMedicineImmunologyCcl4-induced Liver FibrosisChronic InflammationPathologyAngelica Sinensis PolysaccharideHepatotoxicityLiver DiseaseHepatology FibrosisPharmacologyDrug-induced Liver InjuryCirrhosis